<DOC>
	<DOCNO>NCT00971152</DOCNO>
	<brief_summary>This goal study evaluate outcome vitro fertilization cycle 450 IU daily dose gonadotropin administer compare 600 IU daily dose administer woman risk poor ovarian response order determine one dose result improved cycle outcome .</brief_summary>
	<brief_title>Effect Higher Than Maximum 450IU Gonadotropin Dose In-vitro Fertilization Cycle</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>RESIDENT OF CANADA Premenopausal Age 40 year less time enrollment At risk poor ovarian response define : either &lt; 5 oocyte &lt; 8 follicle previous cycle , FSH &gt; 10 IU/L , AMH &lt; 1 pg/ml , antral follicle count less equal 8 previous IVF cancellation Primary infertility secondary Not previously undertaken cycle include study Simultaneous participation another clinical trial Body mass index ( BMI ) &gt; 38 kg/m2 Early follicular phase ( day 24 ) serum FSH level &gt; 20 mIU/ml Any contraindication pregnant carry pregnancy term Contraindication use Estrace速 , Suprefact速 , Menopur速 , Bravelle速 , hCG , luteal phase support medication Any ovarian abdominal abnormality may interfere adequate transvaginal ultrasound evaluation Administration investigational drug within three month prior study enrollment Patient able communicate adequately investigator comply requirement entire study Positive result screen either partner HIV antibody , Hepatitis B ( surface antibody present vaccination ) Hepatitis C Unwillingness give write informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>IVF</keyword>
	<keyword>dose comparison gonadotrophin</keyword>
	<keyword>poor responder ovarian stimulation</keyword>
</DOC>